Clinical Trial Update: Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated epoetin alfa for treating anemia in patients with lymphoma, chronic lymphocytic leukemia, or multiple myeloma who developed anemia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Lymphocytic Leukemia
• Lymphoma
• Multiple Myeloma

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Anemia, Leukemia | Phase 3 | Status: COMPLETED